Get complete access to comprehensive company data for Biocon Biopharmaceuticals Limited.
Complete Report
One-time • Full access
Credit Plan
Pay as you go • Instant
Processing your request...
Downloading your report...
Success
Request Company Screening
Biocon Biopharmaceuticals Limited
Once your screening request is processed, you will receive a notification and the complete report will be available in PDF format for download from your account dashboard.
₹ 44.00 cr
₹ 17.60 cr
17 Jun 2002
31 Mar 2013
Biocon Biopharmaceuticals Limited is an Indian public limited company incorporated on 17 Jun 2002. The company's registered office is situated in Bangaluru, Karnataka, India.
The current status of Biocon Biopharmaceuticals Limited is Amalgamated. The company has filed its annual returns and financial statements up to 31 Mar 2013 (FY 2012-2013).
Biocon Biopharmaceuticals Limited is a company limited by shares with an authorized capital of ₹44.00 cr and a paid-up capital of ₹17.60 cr as per the records maintained by the Ministry of Corporate Affairs (MCA).
Biocon Biopharmaceuticals Limited has 4 directors and 1 signatories. The Key Managerial Personnel (KMP) at Biocon Biopharmaceuticals Limited include Sridevi Bhamidipati as Company Secretary. The directors of the company include John Mccallum Marshall Shaw, Kiran Mazumdar Shaw, Arun Suresh Chandavarkar, Chinappa Muckatira Bhemaiah.
The registered office of Biocon Biopharmaceuticals Limited is located at 20Th Km Hosur Road,Electronic City P O Bangalore Bangalore Karnataka 560100 India in Bangaluru, Karnataka, India.
- CIN/LLPIN/FCRN: U24231KA2002PLC030643
- Legal Name: Biocon Biopharmaceuticals Limited
- ROC Code: Roc Bangalore
- Company No.: 030643
- Company Category: Company Limited By Shares
- Company Sub Category: Non-Government Company
- Company Class: Public
- Listing Status: Unlisted
- Industry: Manufacture Of Chemicals And Chemical Products
- Date of AGM: 25 Jul 2013
🔒 14.3%
(FY 202_)🔒 8.9%
(FY 202_)🔒 12.7%
(FY 202_)🔒 9.5%
(FY 202_)🔒 11.8%
(FY 202_)🔒 15.2%
(FY 202_)🔒 10.6%
(FY 202_)🔒 13.4%
(FY 202_)
Financial Performance Overview
| Financial Metric | FY 2023 | Growth | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
| Total Revenue | 12,45,67,890 | +191.42% | 4,26,78,123 | 3,89,45,234 | 2,98,12,456 | 2,15,67,890 |
| Revenue from Operations | 11,98,45,678 | +176.82% | 4,32,10,987 | 3,78,90,123 | 2,89,45,678 | 2,10,23,456 |
| Total Assets | 45,67,89,012 | +61.07% | 28,34,56,789 | 24,56,78,901 | 19,87,65,432 | 16,54,32,109 |
| Profit or Loss | -1,23,45,678 | 24.56% | 4,32,109 | 2,15,678 | 1,89,234 | 1,23,456 |
| Net Worth | 12,34,56,789 | 85.66% | 85,67,89,012 | 78,90,12,345 | 65,43,21,098 | 54,32,10,987 |
| EBITDA | 2,34,56,789 | +6604.87% | 3,49,012 | 2,10,987 | 1,56,789 | 98,765 |
| Past Director Details of Biocon Biopharmaceuticals Limited |
|---|
Frequently Asked Questions
- arun suresh chandavarkar
- chinappa muckatira bhemaiah
- john mccallum marshall shaw
- kiran mazumdar shaw
- sridevi bhamidipati